Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study von Popa, S., Moţa, M., Popa, A., Moţa, E., Serafinceanu, C., Guja, C., Catrinoiu, D., Hâncu, N., Lichiardopol, R., Bala, C., Popa, A., Roman, G., Radulian, G., Timar, R., Mihai, B.

Volltext

Improving arterial stiffness in overweight and obese subjects after weight loss intervention von Elian, V, Dragomirescu, L, Cheta, D.M, Serafinceanu, C

Volltext

CHOICE OF THE ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES PATIENTS IN CLINICAL PRACTICE. INITIAL RESULTS FROM A NON-INTERVENTIONAL MULTICENTER STUDY IN ROMANIA (REALITY) von Serafinceanu, C, Timar, R, Catrinoiu, D, Zaharia, A

Volltext

Impact of gender and dialysis modality on early mortality risk in diabetic ESRD patients: data from a large single center cohort von Serafinceanu, C., Neculaescu, C., Cimponeriu, D., Timar, R., Covic, A. C.

Volltext

Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes von Panduru, N M, Moţa, E, Moţa, Maria, Cimponeriu, D, Serafinceanu, C, Cheţa, D M

Volltext

MTRR polymorphism and the risk for colorectal and breast cancer in Romanian patients--a preliminary study von Burcoş, T, Toma, M, Stavarachi, M, Cimponeriu, D, Apostol, P, Popa, E, Stăñilescu, S, Popa, I, Radu, I, Serafinceanu, C, Panduru, N, Beluşică, L, Gavrilă, L

Volltext

Arginine catabolism is driven mainly towards NO synthesis in erythrocytes of patients with type 2 diabetes at first clinical onset von Savu, O., Bradescu, O.-M., Serafinceanu, C., Iosif, L., Grajdeanu, I.-V., Stoian, I.

Volltext

PP69 - Arginine catabolism is driven mainly towards NO synthesis in erythrocytes of patients with type 2 diabetes at first clinical onset von Savu, O., Bradescu, O.-M., Serafinceanu, C., Iosif, L., Grajdeanu, I.-V., Stoian, I.

Volltext

The increased antioxidant activity in erythrocytes may compensate for the failure of plasma antioxidants in late type 2 diabetes patients von Savu, O., Bradescu, O.M., Iosif, L., Ionescu Tirgoviste, C., Serafinceanu, C., Stoian et al⁎, I.

Volltext

Galactosemia: diagnosis and treatment von Serafinceanu, Nakisa, Cucu, I C, Serafinceanu, C

Volltext

Myofibroblast involvement in tubular basement membrane remodeling in type II diabetic nephropathy von Mandache, E, Gherghiceanu, Mihaela, Serafinceanu, C, Penescu, M, Mircescu, G

Volltext

The Association between Adipokines, Insulin Resistance Markers and Microalbuminuria in Obese Type 2 Diabetic Patients von Bãcanu, E

Volltext

WEIGHT LOSS IN YOUNG OBESE SUBJECTS IMPROVES LIPIDS AND ADIPOKINES LEVELS AND REDUCES ARTERIAL STIFFNESS von Elian, V

Volltext

Investigation of P213S SELL gene polymorphism in type 2 diabetes mellitus and related end stage renal disease. A case-control study von Stavarachi, Monica, Panduru, N M, Serafinceanu, C, Moţa, E, Moţa, Maria, Cimponeriu, D, Ion, Daniela Adriana

Volltext

Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes von Panduru, N M, Cimponeriu, D, Cruce, M, Ion, Daniela Adriana, Moţa, E, Moţa, Maria, Serafinceanu, C, Chivu, Laura Ioana, Panduru, Mihaela, Chivu, R D, Covic, A C

Volltext

Risk Factors for Early Death on Hemodialysis in Diabetic Patients. Romanian 10-Year Experience von Serafinceanu, Cristian C, Stanciu, Cristian C, Enculescu, Dan I, Dan Mircea I Cheta

Volltext

The Vitamin D Receptor and ACE Gene Polymorphisms Contribution to the Progression of Diabetic Nephropathy to End Stage Renal Disease in Romanian Population von Serafinceanu, Cristian C, Cimponeriu, Dan P, Craciun, Anne-Marie G, Coman, Anca I

Volltext

Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort von Van Biesen, Wim, Williams, John D, Covic, Adrian C, Fan, Stanley, Claes, Kathleen, Lichodziejewska-Niemierko, Monika, Verger, Christian, Steiger, Jurg, Schoder, Volker, Wabel, Peter, Gauly, Adelheid, Himmele, Rainer

Volltext

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised cont... von Mathieu, Chantal, Phillip, Moshe, Griffen, Steven C, Tschöpe, Diethelm, Thorén, Fredrik, Langkilde, Anna Maria, Proietto, Joseph, Stranks, Stephen, Chen, Roger, Pape, Alexia, Forbes, Mark, Morbey, Claire, Schnack, Christoph, Fliesser-Goerzer, Evelyn, Hoelzl, Bertram, Prager, Rudolf, Vercammen, Chris, Mathieu, Chantal, Ruige, Johannes, Woo, Vincent, St-Pierre, Bruno, Hramiak, Irene, Krarup Hansen, Troels, Gram, Jeppe, Saltevo, Juha, Taurio, Jyrki, Nieminen, Sakari, Pietilainen, Kirsi, Hadjadj, Samy, Cariou, Bertrand, Borot, Sophie, Tschoepe, Diethelm, Marck, Cornelia, Horacek, Thomas, Rose, Ludger, Goebel, Rolf, Kerenyi, Zsuzsanna, Oroszlan, Tamas, Konyves, Laszlo, Phillip, Moshe, Mosenzon, Ofri, Shehadeh, Naim, Adawi, Faiad, Wainstein, Julio, Dotta, Francesco, Genovese, Stefano, Di Bartolo, Paolo, Mannucci, Edoardo, Lapolla, Annunziata, Esteban, Alberto, Ruiz, Bazzoni, Ramirez, Guillermo Mondragon, Pelayo Orozco, Emilia, Medina Pech, Carlos, Sauque Reyna, Leobardo, Llamas Esperon, Guillermo, Nevarez Ruiz, Luis Alejandro, Vidrio Velazquez, Maricela, Garcia-Hernandez, Pedro Alberto, Araujo-Silva, Roberto, Villeda - Espinosa, Efrain, Popescu, Daniela, Constantin, Ciprian, Popa, Bogdan, Timar, Romulus, Pintilei, Ella, Gimenez, Margarita, Mezquita, Pedro, Eriksson, Jan, Londahl, Magnus, Eliasson, Bjorn, Gunstone, Anthony, Heller, Simon, Darzy, Ken, Mansell, Peter, Davies, Melanie, Courtney, Hamish, Turner, Wayne, Blagden, Mark, McCrimmon, Rory, Lane, Wendy, Lucas, Kathryn, White, Judith, Jantzi, Curtis, Ervin, William, Cleland, Alan, Fink, Raymond, Rodbard, Helena, Nakhle, Samer, Bays, Harold, Kane, Laurie, Ipp, Eli, Garg, Satish, Bhargava, Anuj, Rosenstock, Julio, Young, Laura, Aroda, Vanita, Pettus, Jeremy, Liljenquist, David, Dandona, Paresh

Volltext

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease von Yale, J.-F., Bakris, G., Cariou, B., Nieto, J., David-Neto, E., Yue, D., Wajs, E., Figueroa, K., Jiang, J., Law, G., Usiskin, K., Meininger, G.

Volltext